Skip to content

Industrial Pharmacist

  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy
  • ANDA
  • ADL
  • FRD
  • QbD
  • QA
  • QC
  • RA
  • FDA
  • VS
  • SCM
  • Q&A
  • Dissolution
  • Data Integrity
  • Validation
  • Manufacturing
  • Packaging
  • Microbiology
Industrial Pharmacist
  • Audit and Inspection Readiness in Pharmaceutical Industry
    Audit | Compliance

    Audit and Inspection Readiness in Pharmaceutical Industry

    Byipharmacist July 27, 2023September 11, 2024

    As a life science sector audit and inspection are common terms in pharmaceutical industry. Here we going to mention a list of criteria of maintaining audit and inspection readiness at all times in pharma industry.   1. Clear Communication Channel Manufacturing and quality teams should establish clear communication channels. Regular meetings and discussions enable both…

    Read More Audit and Inspection Readiness in Pharmaceutical IndustryContinue

  • pH and pKa Concepts in Method Development by HPLC
    Analytical Development | pH

    pH and pKa Concepts in Method Development by HPLC

    Byipharmacist July 25, 2023September 11, 2024

    pH and pKa are two important concepts in chemistry that are often confused. pH   pKa   The relationship between pH and pKa pH = pKa + log(A-/HA)   Where,   Is pKa the same as pH? It is important to remember that when the pH equals to pKa value, the proportions of conjugate base…

    Read More pH and pKa Concepts in Method Development by HPLCContinue

  • Root Cause Analysis in Pharmaceutical Industry
    QRM

    Root Cause Analysis in Pharmaceutical Industry

    Byipharmacist July 25, 2023September 11, 2024

    “In many organization, politics are allowed to influence the CAPAs simply because there are too many people involved in the approval process—approval to actually open a CAPA, or approval to finish one.   Very often there are too many people, or the wrong people, in the approval process. I’ve seen real problems get swept under…

    Read More Root Cause Analysis in Pharmaceutical IndustryContinue

  • Non-Sink Conditions in Dissolution Testing
    Dissolution

    Non-Sink Conditions in Dissolution Testing

    Byipharmacist July 24, 2023September 11, 2024

    Non-sink conditions refer to situations where the concentration of the drug substance in the dissolution medium is not significantly lower than its solubility.   While sink conditions are commonly preferred in dissolution testing to ensure rapid and complete drug dissolution, there are certain instances where non-sink conditions can be useful. Here are a few examples:…

    Read More Non-Sink Conditions in Dissolution TestingContinue

  • Guide to Determine Sink Conditions in Dissolution Testing
    Dissolution

    Guide to Determine Sink Conditions in Dissolution Testing

    Byipharmacist July 24, 2023September 11, 2024

    Sink conditions refer to a state in which the dissolution medium has sufficient volume to ensure the drug dissolves rapidly without reaching saturation throughout the duration of the test.  Sink conditions = V/Vsat ≥ 3 Where,    Volume of Dissolution Medium The volume of the dissolution medium should be at least 3-10 times the saturation…

    Read More Guide to Determine Sink Conditions in Dissolution TestingContinue

  • How to Correctly Manage Quality Defects and Recalls?
    EMA | Market Complaints

    How to Correctly Manage Quality Defects and Recalls?

    Byipharmacist July 23, 2023September 11, 2024

    In Europe, The EMA coordinates the assessment of reports of product quality defects of centrally authorized medicines.   Medicinal products with a quality defect are not of the correct quality as defined by their marketing authorization.   It is important to report these defects in a timely manner because sometimes it is necessary to implement…

    Read More How to Correctly Manage Quality Defects and Recalls?Continue

  • Corrective and Preventive Action (CAPA) in Pharmaceutical Industry
    CAPA | Deviation | QRM

    Corrective and Preventive Action (CAPA) in Pharmaceutical Industry

    Byipharmacist July 23, 2023September 11, 2024

    Corrective and Preventive Action (CAPA) was first formally introduced by the U.S. Food and Drug Administration (FDA) in 2006 as a component of the Quality Systems Guidance. This guidance would go on to form the basis of the ICH Q10.   Since then, it’s found its way into the EU GMP Guide, laying out the…

    Read More Corrective and Preventive Action (CAPA) in Pharmaceutical IndustryContinue

  • Basic Tools for Root Cause Analysis (RCA) in Pharmaceutical Industry
    CAPA | Deviation | QRM

    Basic Tools for Root Cause Analysis (RCA) in Pharmaceutical Industry

    Byipharmacist July 22, 2023September 11, 2024

    Root Cause Analysis (RCA) is a problem-solving methodology that steps you through the RCA process. Each RCA process phase has a range of root cause analysis tools that you can use.   The RCA process starts at the problem event then moves through evidence collection, investigation, analysis, developing corrective actions to address the problem or…

    Read More Basic Tools for Root Cause Analysis (RCA) in Pharmaceutical IndustryContinue

Page navigation

Previous PagePrevious 1 … 39 40 41 42 43 Next PageNext

Popular Articles

  • Calculation of Peak Purity in HPLC

    Calculation of Peak Purity in HPLC

  • Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

    Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

  • Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

    Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

  • Audits in the Pharmaceutical Industry | Internal vs External

    Audits in the Pharmaceutical Industry | Internal vs External

  • USFDA Complaint Laboratory KPIs Measurements

    USFDA Complaint Laboratory KPIs Measurements

  • Difference Between Generic ANDA and 505(b)(2) Submissions

    Difference Between Generic ANDA and 505(b)(2) Submissions

  • Difference Between Disinfection and Sterilization

    Difference Between Disinfection and Sterilization

  • Key Elements of an Analytical Worksheet

    Key Elements of an Analytical Worksheet

  • Interview Questions and Answers on GMP

    Interview Questions and Answers on GMP

  • Quality by Design (QbD) and Design Space in Pharmaceutical Development

    Quality by Design (QbD) and Design Space in Pharmaceutical Development

  • CPP and CQA in Different Stages of Drug Product Manufacturing

    CPP and CQA in Different Stages of Drug Product Manufacturing

  • FDA Recall Classification System

    FDA Recall Classification System

  • Analytical Test Method Validation and Verification

    Analytical Test Method Validation and Verification

  • GLP vs GMP vs GCP | Similarities and Differences

    GLP vs GMP vs GCP | Similarities and Differences

  • Pharmaceutical Validation Interview Questions and Answers

    Pharmaceutical Validation Interview Questions and Answers

  • Difference Between Purity and Potency

    Difference Between Purity and Potency

  • Difference Between RLD and RS

    Difference Between RLD and RS

  • USFDA Databases

    USFDA Databases

  • Regulatory Requirements for Reprocess and Re-work

    Regulatory Requirements for Reprocess and Re-work

  • What Does FDA Regulate?

    What Does FDA Regulate?

© 2025 Industrial Pharmacist

  • Privacy Policy
  • DMCA
  • Contact Us
Industrial Pharmacist
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy